Autoantibodies to Potassium Channel KIR4.1 in Multiple Sclerosis
Open Access
- 1 January 2013
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 4, 35883
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Potassium Channel KIR4.1 as an Immune Target in Multiple SclerosisNew England Journal of Medicine, 2012
- Is Multiple Sclerosis an Autoimmune Disease?Autoimmune Diseases, 2012
- B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and Is Increased in Multiple Sclerosis PatientsThe Journal of Immunology, 2011
- Evidence-based guideline update: Plasmapheresis in neurologic disorders [RETIRED]Neurology, 2011
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in miceBrain, 2010
- Modulation of Kir4.1 and Kir4.1–Kir5.1 channels by small changes in cell volumeNeuroscience Letters, 2009
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple SclerosisNew England Journal of Medicine, 2008
- Multiple sclerosis: a complicated picture of autoimmunityNature Immunology, 2007
- Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosisBrain, 2007
- Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patientsJournal of Neuroimmunology, 2006